MyFinsight
Home
Blog
About
NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. (NAMS)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
976.02%
Quick Ratio
976.02%
Cash Ratio
678.73%
Debt to Asset Ratio
9.20%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Marketable securities, current
Marketable securities, net of cu...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated loss
Derivative warrant liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
457,607
490,002
538,407
563,864
Prepayments and other receivables
20,603
38,138
28,074
30,688
Marketable securities, current
178,498
146,239
164,539
175,298
Restricted cash
1,336
1,321
1,308
-
Total current assets
658,044
675,700
732,328
769,850
Marketable securities, net of current portion
71,239
92,609
53,091
44,172
Property, plant and equipment, net
379
383
323
312
Operating right of use asset
21
185
246
308
Intangible assets
375
407
439
470
Long term prepaid expenses
2,585
-
-
-
Total assets
732,643
769,284
786,427
815,112
Accounts payable
8,090
8,970
3,632
5,895
Accrued expenses and other current liabilities
5,092
15,422
10,098
9,460
Deferred revenue, current
3,987
3,987
-
-
Lease liability, current
23
136
181
225
Derivative warrant liabilities
50,229
57,272
44,361
20,932
Total current liabilities
67,421
85,787
58,272
36,512
Lease liability, net of current portion
-
66
85
103
Total liabilities
67,421
85,853
58,357
36,615
Ordinary shares
14,594
14,278
14,107
14,014
Additional paid-in capital
1,457,238
1,426,750
1,396,790
1,375,618
Accumulated loss
-810,831
-762,390
-687,467
-615,462
Accumulated other comprehensive income
4,221
4,793
4,640
4,327
Total shareholders' equity
665,222
683,431
728,070
778,497
Total liabilities and shareholders' equity
732,643
769,284
786,427
815,112
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$457,607K
Marketable securities,
current
$178,498K
Prepayments and other
receivables
$20,603K
Restricted cash
$1,336K
Total current assets
$658,044K
Marketable securities, net
of current portion
$71,239K
Long term prepaid
expenses
$2,585K
Property, plant and
equipment, net
$379K
Intangible assets
$375K
Operating right of use
asset
$21K
Total assets
$732,643K
Total liabilities and
shareholders' equity
$732,643K
Total shareholders'
equity
$665,222K
Total liabilities
$67,421K
Accumulated loss
-$810,831K
Additional paid-in capital
$1,457,238K
Total current
liabilities
$67,421K
Ordinary shares
$14,594K
Accumulated other
comprehensive income
$4,221K
Derivative warrant
liabilities
$50,229K
Accounts payable
$8,090K
Accrued expenses and
other current...
$5,092K
Deferred revenue,
current
$3,987K
Lease liability,
current
$23K
Buy us a coffee